Roche Receives CE Mark for PCR Test Targeting Bacterial Vaginosis and Candida Vaginitis
The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
Join Tosoh Bioscience and Dr. Giuliana Puccini Santamaria for a deep dive into fertility markers and their role in diagnosing and managing infertility. This webinar explores key indicators like ovarian function, polycystic ovarian syndrome, and the importance of fast, accurate immunoassay results in fertility treatment. Ideal for clinicians seeking actionable insights in reproductive health.
A new study suggests that neuroactive steroid levels in the third trimester may predict postpartum depression risk.
A blood test measuring the fibrinogen-to-albumin ratio can predict the risk of preeclampsia in laboring women, improving maternal outcomes.
Read MoreResearchers discovered a potential stool test and therapy for endometriosis, based on bacterial metabolites linked to the condition.
Read MoreA specific genetic variant found in about 7% of Dutch women reduces the accuracy of NIPT, increasing the likelihood of inconclusive results.
Read MoreClearNote’s ovarian cancer test has been issued a new CPT code by the AMA and preliminary reimbursement rate determinations from CMS.
Read MoreA study found that elevated blood levels of LDL cholesterol, Lp(a), and CRP significantly increase long-term cardiovascular risk.
Read MoreEndometriosis affects over 11% of women and remains challenging to diagnose early, with researchers exploring new diagnostic methods.
Read MoreResearchers are using advanced AI technology, EpiSign, to diagnose rare genetic diseases and prenatal exposure-related birth abnormalities.
Read MoreGattaca Genomics aims to enhance family-building through advanced prenatal genetic screening, increasing the success rates and access.
Read MoreA new home-based questionnaire can identify individuals at high risk of heart attacks with the same accuracy as clinical blood tests.
Read MoreMenarini Silicon Biosystems presented a study, about its advanced non-invasive prenatal testing technology using maternal blood.
Read MoreMeasuring blood levels of homocysteine can help predict the risk and progression of obstructive sleep apnea.
Read MoreRecent advancements in congenital CMV (cCMV) screening underscore the need for enhanced awareness and legislative action.
Read MoreThe test monitors pregnant women for Toxoplasma gondii infections, and detects infections within 30 minutes from a finger-prick.
Read MoreLabs should consider self-reported race when screening for open neural tube defects to improve prenatal care equity for Black individuals.
Read MoreLabcorp has introduced a first trimester preeclampsia screening test to assess preeclampsia risk between 11- and 14-weeks’ gestation.
Read More